Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB26FX4NF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,735
Award facts
- Contract value 100% obligated
- $1,734.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Wegovy 2.4 mg/0.75 ml pen injections valued at $1,734.92. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 10, 2025. The work will be performed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply agreement valued at $999.999 billion through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare customers. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As the prime contractor under the SPE2DX IDC, AmerisourceBergen fulfills a strategic role in the DLA Troop Support Medical Supply Chain, providing flexible pharmaceutical support to military healthcare programs worldwide. This delivery order for Wegovy, an injectable diabetes and weight management medication, exemplifies the company's capability to supply specialized pharmaceutical products meeting federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DB26FX4NF?
SPE2DB26FX4NF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FX4NF worth?
The government has obligated $1,735 on SPE2DB26FX4NF.
Is contract SPE2DB26FX4NF an order under another contract?
Yes. SPE2DB26FX4NF is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4NF competed?
The extent of competition for SPE2DB26FX4NF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award